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Denitrification is a microbial pathway that constitutes an important part of the nitrogen cycle on earth. 
Denitrifying organisms use nitrate as a terminal electron acceptor and reduce it stepwise to nitrogen 
gas, a process that produces the toxic nitric oxide (NO) molecule as an intermediate. In this work, we 
have investigated the possible functional interaction between the enzyme that produces NO; the cd1 
nitrite reductase (cd1NiR) and the enzyme that reduces NO; the c-type nitric oxide reductase (cNOR), 
from the model soil bacterium P. denitrificans. Such an interaction was observed previously between 
purified components from P. aeruginosa and could help channeling the NO (directly from the site of 
formation to the side of reduction), in order to protect the cell from this toxic intermediate. We find 
that electron donation to cNOR is inhibited in the presence of cd1NiR, presumably because cd1niR 
binds cNOR at the same location as the electron donor. We further find that the presence of cnoR 
influences the dimerization of cd1NiR. Overall, although we find no evidence for a high-affinity, constant 
interaction between the two enzymes, our data supports transient interactions between cd1niR and 
cNOR that influence enzymatic properties of cNOR and oligomerization properties of cd1niR. We 
speculate that this could be of particular importance in vivo during metabolic switches between aerobic 
and denitrifying conditions.
Denitrification is an anaerobic process in which nitrate (NO3−) is reduced stepwise to nitrogen gas (N2) via the 
intermediates nitrite, nitric oxide and nitrous oxide. There is widespread interest in denitrification because it 
limits the amount of nitrogen available to crops by decreasing the amount of nitrate and nitrite in the soil and 
because incomplete denitrification yields nitrous oxide which is a potent green-house gas. In Paracoccus (P.) 
denitrificans, a model organism for both aerobic respiration and denitrification, the enzymes that catalyze these 
reactions are: nitrate reductase (NAR), reducing nitrate to nitrite, nitrite reductase (NiR) which reduces nitrite 
to nitric oxide, nitric oxide reductase (NOR), reducing nitric oxide to nitrous oxide and finally nitrous oxide 
reductase (N2OR), which reduces nitrous oxide to nitrogen gas (for a review on denitrification enzymes, see1).
The stepwise reduction of nitrate requires the product of one enzyme to be the substrate for the next enzyme 
in the pathway and as a consequence the expression of all four enzymes should be coordinated and regulated in 
such way that the concentrations of nitrite and nitric oxide are kept at concentrations that are not toxic to the 
cell2. Lethal nitric oxide concentrations have been shown to vary between organisms, with some bacteria such as 
Agrobacterium tumefaciens accumulating µM NO concentrations during rapid switches between oxic and anoxic 
conditions, but in P. denitrificans nitric oxide is kept at (or below) ~30 nM3.
The enzyme catalyzing the reduction of nitrite to nitric oxide (NO2− + e− + 2 H+ →NO + H2O) in P. denitrif-
icans is cytochrome cd1 nitrite reductase (cd1NiR), a soluble protein located in the periplasm (for a recent review 
on cd1NiR and nitrite, see4). The almost identical (97% sequence identity) and well characterized cd1NiR from 
Paracoccus pantotrophus is purified5 and crystallized as a dimer6. Each cd1NiR monomer consists of one small 
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heme c domain and one large d1 domain, where NO2− reduction takes place. The heme c domain receives elec-
trons from one of two soluble donors; either cytochrome c550 or the copper protein pseudoazurin7. The heme d1 in 
the catalytic domain has an unusual ability (as compared to other hemes) to rapidly release NO, thereby lowering 
the degree to which the cd1NiR enzyme activity is inhibited by its product NO8.
The well-characterized cd1NiRs from P. pantotrophus and Pseudomonas (Ps) aeruginosa (see e.g.9 and4) have 
many properties in common including a similar overall fold especially in the larger, catalytic d1 domain. They 
also use similar electron donors; a soluble c cytochrome or a blue copper protein. However, there are also strik-
ing differences, such as the ‘domain swapping’ that occurs only in the Ps. aeruginosa cd1NiR dimer, where the 
N-terminal arm (in the cyt. c domain) of one monomer crosses over to interact with the d1 domain of the second 
monomer.
Nitric oxide, produced from cd1NiR, is further reduced to nitrous oxide (2NO + 2e− + 2 H+ →N2O + H2O), by 
nitric oxide reductase (NOR). NORs are members of the heme-copper oxidase (HCuO) superfamily. This super-
family (comprising the cytochrome c oxidase in mitochondria) is large and diverse and some of its members are 
capable of NO-reduction10–12, and all that have been investigated also show that the physiological O2-reduction 
reaction is inhibited by NO (reviewed in13,14, see also15), an effect which is linked to the use of NO as a signaling 
molecule in mammals16.
The NOR from P. denitrificans is a cytochrome c-dependent NOR (cNOR) that, as purified, is composed of 
two subunits; NorB and NorC. The NorB is an integral membrane protein and harbors a low-spin heme b and the 
active site, composed of a high-spin heme b3 and a non-heme iron, FeB. NorC is membrane-anchored and con-
tains a periplasmic heme c, which receives electrons from soluble donors such as cytochrome c or pseudoazurin 
(the same as for cd1NiR). The enzyme uses protons and electrons from the same side of the membrane (periplas-
mic, see17,18) and is thus non-electrogenic19,20, which differs from the O2-reducing HCuOs. The crystal structure 
of the cNOR from P. aeruginosa supports this as putative proton transfer pathways are only found leading from 
the periplasm into the active site21.
Respiratory chain complexes in mitochondria commonly form higher-order complexes, so-called supercom-
plexes. Such supercomplexes have also been found in bacteria (see e.g.22,23), but the functional advantage of them 
is not always fully understood. Recently, the crystal structure of a complex between separately purified cd1NiR 
and cNOR from Ps. aeruginosa was presented24. The complex has a 2:2 stoichiometry (dimer of cd1NiR with two 
monomers of cNOR), and the interaction was suggested to be present also under native conditions, but then in a 
2:1 stoichiometry since the membrane-location of cNOR is not compatible with the 2:2 complex observed. Such a 
cd1NiR-cNOR complex could confer advantages in vivo as the toxic NO molecule would, instead of being released 
into the periplasmic solution, rather be ‘channeled’ into the membrane in which it is more soluble. From the 
membrane, NO could directly enter the gas channel suggested for cNOR21,25, see Fig. 1.
The aim of this work was to determine whether the P. denitrificans cd1NiR and cNOR form a molecular com-
plex in vivo and/or in vitro and to study potential functional interactions in vitro. To this end we investigated the 
localization of cd1NiR in P. denitrificans, and we also used the cNOR catalyzed reaction as an in vitro ‘handle’ to 
report on a possible complex with cd1NiR. We also used fluorescence spectroscopy to investigate cd1NiR dimeri-
zation and the interactions of cd1NiR with artificial and native membranes as well as with cNOR. Our data implies 
interference from cd1NiR binding on electron donation to cNOR, consistent with an overlapping interaction 
surface. This effect of cd1NiR on cNOR activity shows a titration profile consistent with an interaction primarily 
with a single cd1NiR monomer. Our fluorescence data is consistent with this dimerization occurring in the rele-
vant concentration range (20–40 nM cd1NiR). However, we could not observe any clear long-lived high-affinity 
binding between cd1NiR and cNOR going beyond the rather high affinity cd1NiR showed to artificial membranes, 
nor could we observe a large fraction of the cd1NiR associated with the membrane-bound cNOR in P. denitrificans 
membranes. Potential in vivo consequences of our results are discussed.
Results
The influence of cd1niR on catalytic activity of cnoR. If cNOR and cd1NiR interact with each other, 
they could influence each other’s catalytic parameters, therefore we measured the influence of the presence of 
cd1NiR on NO-reduction by cNOR (which is straightforward to measure). Surprisingly, we observed clear inhibi-
tion of cNOR-catalyzed NO-reduction in the presence of cd1NiR, see Fig. 2a. NO-reduction by the P. denitrificans 
cNOR exhibits a sigmoidal curve, due to substrate inhibition26,27 at NO > 10 µM. The value we report for cNOR 
activity is the maximum activity (kmax, note that this kmax is not a kcat since there is substrate inhibition at higher 
[NO]) observed at ~5 µM NO. In the presence of cd1NiR (Fig. 2a), two effects are observed; the maximum activity 
is lowered and the substrate inhibition pattern changes, see below.
We investigated the inhibitory effect as a function of cd1NiR concentration added, the raw data is shown 
in Supporting Fig. 1, and a plot of the maximum rate as a function of added cd1NiR is shown in Fig. 2b (and 
Supporting Fig. 2). The maximum activity of cNOR decreases gradually the more cd1NiR is added and the 
effect reaches a maximum level of inhibition (~50%) at ~30 nM cd1NiR (approximately equimolar to cNOR). 
Surprisingly, at higher concentrations of cd1NiR, the inhibition is released (Fig. 2b), the possible reasons for this 
are discussed further below (see Fluorescence section). For the investigations of the influence of the electron 
donor described in the next section, we used the cd1NiR concentration (and cNOR/cd1NiR ratio) giving the 
maximum inhibition.
electron donation to cNOR in the presence of cd1niR. In the co-crystal structure of the complex 
between the cd1NiR and cNOR from P. aeruginosa24, the interaction surface (see Fig. 1) could possibly overlap 
with interaction of the electron donor to cNOR. Thus, one reason for the inhibition observed with cd1NiR could 
be that it interferes with electron donation, and we therefore studied the titration behavior of electron donors for 
cNOR catalysis in the absence and presence of cd1NiR.
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Figure 1. Structure of the co-complex of the P. aeruginosa cNOR and the cd1NiR dimer (PDB ID: 5GUW24). 
(a) The full 2:2 structure with the two cNOR molecules in light green (NorC) and teal (NorB) and the cd1NiR 
dimer in blue/gray. (b) Enlargement of the co-complex interaction area for cd1NiR and a single cNOR, with 
the interaction between Arg-71 (cd1NiR, blue stick) and Glu-119 (cNOR, green stick) shown. Also shown are 
schematic outlines of the cytoplasmic membrane in which cNOR sits and the path for NO from the release from 
the d1 heme of cd1NiR (pink) into the membrane from which it would travel through the suggested gas channel 
(indicated by green sticks) to the active site heme b3 (pink) in cNOR25. Also highlighted is the initial electron-
accepting heme c in NorC (pink), other heme groups in grey.
Figure 2. The inhibitory effect of cd1NiR on cNOR catalysis. (a) NO reduction profile of P. denitrificans cNOR 
in the absence (black line) and presence (red line) of cd1NiR. Experimental conditions: 50 mM HEPES pH 7.0, 
50 mM KCl, 0.05% DDM, 30 mM glucose, 1 U/ml glucose oxidase, 20 U/ml catalase. Once the chamber was 
anaerobic, cyt. c (15 µM), TMPD (0.5 mM), and 5 times 10 µM NO (from NO-saturated water) was added. At t 
~250 s, ascorbate (3 mM) and cNOR (80 nM) were added. For the trace with cd1NiR (80 nM), it was added before 
the addition of NO. (b) Titration of the inhibitory effect of cd1NiR on cNOR catalysis. Experimental conditions as 
in A, except the cNOR concentration was 40 nM, and the cd1NiR concentration varied between 0–200 nM. cNOR 
activity (black circles) refers to the kmax at ~5 µM NO, with the kmax in the absence of cd1NiR set at 100%. Also 
shown is the effect of adding cd1NiR on substrate inhibition (blue circles) for NO-reduction by cNOR. The right 
y-axis refers to the [NO] where kmax/2 is reached (termed Kiapp in the text, note that this is higher than for kmax).
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As a pre-requisite for the investigation of possible interference of electron donation caused by cd1NiR bind-
ing to cNOR, we determined the Km for cytochrome c (horse heart) during NO reduction by cNOR. For these 
titrations, we always used the maximum activity, kmax at ~5 µM NO. The results are shown in Fig. 3a and can be 
fitted with a kmax = 6 ± 1 e−s−1 (electrons/(s•cNOR)) and Km = 0.8 ± 0.3 µM. As seen in this graph, the data is 
scattered and the standard deviation in the Km quite large. We therefore instead measured the activity with cNOR 
reconstituted into liposomes. The aim of this was two-fold, first the activity of P. denitrificans cNOR is higher 
in liposomes17,28, giving us a larger total change in activity during titration and hence smaller relative errors. 
Secondly, the presence of a membrane might influence a putative cNOR-cd1NiR interaction, as suggested for the 
P. aeruginosa complex24. In liposome-reconstituted cNOR, we determined the kmax to 15 ± 1 e−s−1 and the Km for 
cyt. c to 0.8 ± 0.2 µM (Fig. 3a), i.e. no change in Km was observed.
Side by side experiments were conducted to determine the Km for cyt. c of liposome-reconstituted cNOR in 
the absence or presence of ∼30 nM cd1NiR (Fig. 3b). This is the cd1NiR concentration which maximally inhibits 
detergent-solubilized cNOR (Fig. 2b; see also corresponding data for liposome-reconstituted cNOR in Supporting 
Fig. 2). Surprisingly the observed Km was unchanged in the presence of cd1NiR (Km = 0.15 ± 0.05 µM) compared 
to the control (Km = 0.20 ± 0.05 µM) as shown in Fig. 3b. However, the relative kmax in the presence of cd1NiR was 
~50% of the control. Thus, only the kmax and not the Km value is affected, indicating that the cd1NiR and cyt. c do 
not bind at the same place to cNOR.
We note that the Km value determined (in the absence of cd1NiR) in this experiment is different from that 
determined in the previous experiment (Fig. 3a). This is probably due to the Km values being low and therefore the 
data obtained possibly not represented well by a simple Michaelis-Menten fit. Also, the concentration of cd1NiR is 
about equimolar to cNOR and small differences in the relative concentrations between experiments might affect 
the data. These considerations are the reasons for doing comparative experiments ‘side-by-side’.
Since the Km for cyt. c does not change significantly in the presence of cd1NiR, we scrutinized the raw 
data used for Fig. 3b, and re-plotted it without subtracting the background rate (with Ascorbate (Asc)/
tetramethyl-p-phenylenediamine (TMPD)) (see Supporting Fig. 3A). This shows that there is inhibition of the 
basal activity by cd1NiR with only Asc/TMPD to provide electrons that does not change significantly when cyt. c 
is added. This observation suggests that cd1NiR inhibits the electron donation from TMPD rather than that from 
cyt. c. To verify this, we studied the effect of titrating cd1NiR on cNOR catalysis in the absence of TMPD (with 
only cyt. c and Asc), see Supporting Fig. 3B which shows that in the absence of TMPD, there is no inhibition.
We then studied the cNOR activity as a function of the TMPD concentration (with ascorbate, but in the 
absence of cyt. c), both in the absence and presence of cd1NiR, see Fig. 4. Here there is a clear inhibition by cd1NiR. 
The data indicates that there might be more than one interaction with TMPD, but assuming a single binding 
site, the obtained constants are; in the absence of cd1NiR: kmax = 31 ± 2 e−s−1 and Km = 1.2 ± 0.2 mM, and in the 
presence of cd1NiR: kmax = 12 ± 2 e−s−1 and Km = 0.7 ± 0.2 mM. In this scenario, both the kmax and Km are affected 
(so-called mixed inhibition). Our data does not allow for any unambigous fit to a more complex behaviour.
We also observe inhibition by cd1NiR when PMS is used as an electron mediator instead of TMPD (see 
Supporting Fig. 4). Thus, there is an inhibition of cNOR activity by the presence of cd1NiR with both TMPD and 
PMS, indicating that the interaction surface (or part of it, cf. the data with TMPD) on cNOR is similar for TMPD 
and PMS, and that this surface overlaps with cd1NiR binding.
As controls for the measurements described above, we studied the possibility that TMPD directly affects 
auto-reduction of NO, as well as the possibility that small amounts of nitrite formed (from NO) in the buffer 
Figure 3. Determinations of the Km for cytochrome c for NO reduction by cNOR. (a) Comparison between cNOR 
in detergent (blue) and reconstituted in liposomes (grey). Experimental conditions as in Fig. 2, except for with 
liposomes, DDM was omitted. cNOR activity refers to the kmax at ~5 µM NO with the kmax obtained without cyt. c 
subtracted. The lines shown are fits giving kcat = 6 ± 1 (e-/(s•cNOR)), Km = 0.8 ± 0.3 µM cyt. c (blue, detergent) and 
kcat = 15 ± 1 (e-/(s•cNOR)), Km = 0.8 ± 0.2 µM cyt. c (dark grey, liposomes). (b) Comparison between liposome-
reconstituted cNOR in the absence (black) and presence (red) of cd1NiR. cNOR activity refers to the kmax at 
~5 µM NO, with the kmax at 3 µM cyt. c in the absence of cd1NiR set at 100%. The curves were fitted as in a, giving 
Km  = 0.20 ± 0.05 µM cyt. c (black, cNOR only) and kcat = 46 ± 4%, Km = 0.15 ± 0.05 µM cyt. c (red, + cd1NiR). 
Experimental conditions as in (a).
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could have effects interfering with our results. However, we found no effects that were significant enough to 
influence the data presented. For nitrite, we see that it can inhibit cNOR activity, but only at high (mM) concen-
trations, consistent with previous studies29.
Substrate inhibition in cNOR in the presence of cd1niR. As described above, adding cd1NiR during 
NO-reduction by cNOR has two effects; both reducing the maximum activity investigated above, and in changing 
the pattern of substrate inhibition, see Fig. 2 and Fig. S1. Thus, a plot of the NO concentration where kmax/2 is 
reached as a function of cd1NiR added is shown in Fig. 2b (together with the corresponding effects on the kmax). 
Note that this refers to the NO concentration at higher NO (than that which gives kmax) where kmax/2 is reached, 
and therefore refers to an apparent Ki (rather than an apparent Km). We note that the decrease in maximum rate at 
low cd1NiR correlates well to the decrease in the Kiapp for NO (that is a higher apparent affinity for NO at an inhib-
itory site), whereas the Kiapp for NO then roughly saturates at ~40 nM cd1NiR. It is thus clear that even though 
the inhibition on the maximum rate is released at higher cd1NiR, there is still an influence also at higher cd1NiR 
concentrations, indicating an interaction between cNOR and cd1NiR that persists (see Discussion).
SDS page analysis for localization of cd1niR in P. denitrificans. To investigate the localization of 
cd1NiR in P. denitrificans cells grown under denitrifying conditions, cells were fractionated, and the presence of 
cd1NiR analyzed using Western blot with a specific antibody for cd1NiR. The results, shown in Supporting Fig. 5, 
demonstrate that although cd1NiR is present mainly in the periplasm, it is also found in the membrane fraction. 
We investigated many different conditions for this analysis including different detergents and ionic strength, but 
although using a milder detergent (digitonin) for solubilisation of the membrane fraction gave a somewhat larger 
fraction of cd1NiR bound to it, this fraction is still small, see Discussion.
Figure 4. Determination of the Km for TMPD for NO reduction by liposome-reconstituted cNOR in the 
absence (black) and presence (red) of cd1NiR. Experimental conditions, and data treated as in Fig. 3. The black 
line is a single-hyperbolic fit to the cNOR data giving kcat = 31 ± 3 (e−/(s•cNOR)), Km = 1.2 ± 0.2 mM TMPD. 
The red line is the same fit for the cNOR + cd1NiR data, giving kcat = 10 ± 2 (e−/(s•cNOR)), Km = 0.6 ± 0.2 mM 
TMPD.
Figure 5. Fluorescently labeled cNOR (ATTO 594) and cd1NiR (STAR 635) visualized with a laser scanning 
confocal microscope. (a) cNOR was reconstituted in giant unilamellar vesicles (GUVs) and cd1NiR was added 
to the GUV solution. cNOR was detected in the membrane (green GUV) and cd1NiR was found to be highly 
associated with the membrane (red GUV). (b) Fluorescence intensity scan across the membrane (Z-plane), 
from the inside (−) to the outside (+) of a GUV after adding cd1NiR or BSA, labeled with STAR 635. cd1NiR 
(in contrast to BSA) is highly enriched at the membrane surface. For experimental conditions, see Material and 
Methods.
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interactions of cd1niR and cNOR investigated by fluorescence spectroscopy. Purified cd1NiR 
and cNOR proteins were fluorescently labeled with ATTO 594 and STAR 635, respectively. cNOR was successfully 
reconstituted in giant unilamellar vesicles (GUVs), anchored to a biotin-covered glass surface imaged using a 
confocal laser scanning microscope (see Fig. 5a, green GUVs). cd1NiR was then added in equimolar concentra-
tion (to cNOR) to the GUV solution. The cd1NiR was also added to ‘empty’ GUVs. The cd1NiR was found to be 
highly associated with the membrane (Fig. 5a, red GUV). A scan across the membrane (Z-plane, Fig. 5b) showed 
an increase in fluorescence intensity in the membrane plane (Z = 0), i.e. the concentration of cd1NiR is higher at 
the membrane surface than in the surrounding solution. A control with STAR 635-labeled BSA protein (Fig. 5b) 
showed no such increase in the membrane plane.
The possible interaction between cd1NiR and cNOR was then assayed using fluorescence correlation spectros-
copy (FCS, see Methods) in combination with the confocal setup. First, we measured FCS on the reconstituted 
cNOR-ATTO 594 and cd1NiR-STAR 635 simultaneously on the membrane surface and looked for interaction by 
using two-color FCS and cross-correlation analysis (FCCS). However, no significant interaction could be distin-
guished by this approach (Supporting Fig. 6). In agreement with this, there was no significant difference in the 
degree of cd1NiR binding between the GUVs with or without cNOR reconstituted.
To further probe potential interactions, cNOR was reconstituted in DOPC liposomes (LUVs) and the interac-
tion with cd1NiR was assayed by monitoring changes in diffusion of labelled cd1NiR upon binding. The diffusion 
time of the liposomes containing cNOR labelled with ATTO 594 was 2.6 ms determined with FCS (Fig. 6b, black 
trace). This would correspond to a liposome size of approximately 90 nm (corresponding well to the 100 nm 
expected from the LUV-forming protocol). Liposomes containing unlabeled cNOR were added in increasing 
concentrations to a solution containing 5 nM cd1NiR-STAR 635. The diffusion of cd1NiR-STAR 635 alone was 
0.34 ms, corresponding to a hydrodynamic radius of ~100 Å. The addition of liposomes changed the apparent 
diffusion time of cd1NiR indicating that cd1NiR binds to the LUVs containing cNOR (Fig. 6). The fraction of 
bound cd1NiR was determined by fitting the FCS data with a two-component diffusion model (Eq. 1), where the 
amplitude of the component with a long (2.6 ms) diffusion time was taken to represent liposome-bound cd1NiR. 
The amplitudes of the 2.6 ms component (Fig. 6b) were fitted with a simple ligand-binding model (Eq. 2). The 
same experiment was repeated with ‘empty’ LUVs, and the binding constant for liposome binding to cd1NiR, 
compared on the basis of lipid concentration, was ~13 ± 1 μM with and ~22 ± 2 μM (see Fig. 6b) without cNOR 
present in the membrane. This difference is likely within the experimental uncertainties and cd1NiR has a similar, 
rather high, affinity to the liposomes independently of the presence or absence of cNOR.
We also increased the ionic strength in the buffer from 2 to 100 mM (KCl) in order to shield purely electro-
static interactions between cd1NiR and the membrane. However, no decrease in the fraction bound cd1NiR was 
observed (green circles in Fig. 6b) which indicates that the association of cd1NiR to the DOPC membrane is not 
purely electrostatic in nature (see Discussion).
Although diffusion of both cd1NiR and cNOR was detected when measuring FCS on the GUV membrane 
surface, there was no interaction observed using cross-correlation analysis. Thus, neither the titration experi-
ment using small liposomes, nor the FCCS, measured directly on the membrane surface, could detect an inter-
action between cd1NiR and cNOR going beyond the interaction between cd1NiR and the membrane under these 
experimental conditions. However, it should be noted that the rather high-affinity interaction between cd1NiR 
and the DOPC liposomes themselves might ‘hide’ a relatively weak interaction between cNOR and cd1NiR, see 
Discussion.
Figure 6. Interactions between cd1NiR and liposomes, cNOR-liposomes and native membranes. (a) 
Fluorescence autocorrelation curves measured on a sample containing 5 nM cd1NiR-STAR 635 (red), and after 
addition of LUVs containing 2.5 nM cNOR (green). The dashed (black) line is a fit of the data using a model 
with two diffusion times. As references, measurements of a sample containing free dye STAR 635 (red dotted 
line) and a sample with LUVs containing cNOR labelled with ATTO 594 are also shown. (b) Titration of 5 nM 
cd1NiR-STAR 635 with increasing concentrations of LUVs containing unlabeled cNOR in buffer containing 
2 mM KCl (black) or 100 mM KCl (green), and titration with the same amount of LUVs without protein (white). 
The plot shows the amplitude of the slow component where Fmax has been set to 1. The data for LUVs with and 
without protein were fitted with a simple binding model (see text for details). (c) FCS curves from titration 
experiments with native membranes from P. denitrificans grown under aerobic (green) or anaerobic denitrifying 
(red) conditions. Sonicated membranes were added to a solution of 50 nM cd1NiR-STAR 635 (black dotted line). 
A sample with DOPC-liposomes produced in the same way containing cNOR labelled with ATTO 594 is shown 
as reference (black line).
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Since cd1NiR showed such significant interaction with the pure DOPC liposomes, we also wanted to inves-
tigate whether an interaction between cd1NiR and the membrane (with or without cNOR expressed) could be 
observed using native P. denitrificans membranes. Small membrane vesicles were made from cells grown under 
either aerobic or anaerobic denitrifying conditions and mixed with a solution containing 50 nM cd1NiR-STAR 
635. Although cNOR expresses only during denitrifying conditions no differences were observed. The diffusion 
time of cd1NiR-STAR 635 (Fig. 6c) was partly slowed down in both cases with a fraction matching the diffusion 
time (~1.5 ms) of sonicated DOPC liposomes containing cNOR-ATTO 594. In both cases the slow fraction was 
maximum ~ 25% of the total cd1NiR-STAR 635 population, in comparison to up to 85% when using pure DOPC 
liposomes. Although these fractions do not necessarily correspond directly to the fraction bound cd1NiR, we can 
conclude that cd1NiR interacts much more strongly with artificial ‘lipid-only’ liposomes than it does with native 
membranes, see Discussion.
Dimerization of cd1niR. From the functional cNOR-catalyzed NO-reduction data presented above, the 
observed effect of adding increasing amounts of cd1NiR (see Fig. 2b) made us consider that this dependence could 
be linked to dimerization of cd1NiR. cd1NiR is a dimer in the X-ray crystal structures from both P. aeruginosa9,24 
and P. denitrificans6 and also reported to be a dimer in solution5,30, but to our knowledge, there is no reported 
value for the dimerization constant. To further investigate if there is such a cd1NiR dimer dissociation/association 
in the concentration range used, we analyzed the fluorescence intensity from labeled cd1NiR as a function of its 
concentration. The fluorescence intensity as well as the particle number of cd1NiR-STAR 635 obtained by FCS 
(parameter N in Eq. 1) was used to determine the photon count-rate per molecule (CPM). Figure 7 shows that the 
CPM increases with increasing concentrations when adding cd1NiR-STAR 635 alone. Assuming that the majority 
of cd1NiR-STAR 635 is present as a monomer at very low concentrations (<1 nM) an increase in CPM at higher 
concentrations indicates dimerization. In comparison, the CPM of cNOR labelled with the same fluorophore 
(cNOR-STAR 635) showed only a small increase, indicating that there is no change in its oligomeric state in this 
region.
This cd1NiR titration was done both in the presence and absence of cNOR. Interestingly, both the maximum 
CPM for cd1NiR-STAR 635 and its concentration dependence changed when 40 nM cNOR (unlabeled) was pres-
ent in the solution. The CPM data could be fitted using the ligand-binding model (Eq. 2) allowing for a simple 
comparison; the apparent binding constants for the suggested dimerization of cd1NiR-STAR 635 was 3.5 ± 0.1 nM 
without and 5.3 ± 0.2 nM with cNOR present. We observed a slight decrease in CPM at cd1NiR-STAR 635 concen-
trations above 15 nM, but only in the case when cNOR was not present and these data points were not included 
in the fit (dashed line). The maximum CPM reached was lower in the presence of cNOR, indicating either a 
quenching effect, or that even when dimerized, the cd1NiR is influenced by/binds cNOR, or that there is a fraction 
of cd1NiR that cannot dimerize in the presence of cNOR.
Discussion
The denitrification process is tightly controlled in P. denitrificans, in order to avoid release and accumulation of 
toxic intermediates; nitric oxide and (to a lesser degree) nitrite. This control occurs on the level of transcription, 
by a tight coupling of the expression of the enzymes involved (see e.g.31,32). It has also been suggested that in vivo, 
kinetic parameters for cNOR are significantly different from those obtained in vitro, with e.g. a very high NO 
affinity thereby helping to keep the steady-state NO levels low3. A different way to minimize toxic intermediates 
would be to control the enzymes themselves, by e.g. forming a functional complex between cd1NiR and cNOR 
that shuttles the NO produced from cd1NiR directly to cNOR without release into the bulk phase. Support for this 
hypothesis was recently presented in the form of a co-complex structure of the cd1NiR and cNOR from P. aerug-
inosa obtained from separately purified components24, see Fig. 1. It should be noted that in aerobic respiration 
in both eukaryotes and prokaryotes, supercomplexes of individual enzyme components involved are frequently 
found (see e.g.22,23,33 and references therein).
In this work, we investigated the possibility of a cNOR/cd1NiR complex for P. denitrificans, a denitrification 
model bacterium. The two enzymes cd1NiR and cNOR from P. denitrificans share 48% (cNOR) and 61% (cd1NiR) 
overall sequence identity with their counterparts from P. aeruginosa. We purified the cd1NiR from Paracoccus 
pantotrophus and not denitrificans, but these two enzymes are 97% identical.
The addition of cd1NiR during NO-reduction by cNOR shows some intriguing effects. First, both the substrate 
inhibition pattern and maximum rate of NO reduction is affected by cd1NiR (Fig. 2). Since both these parameters 
are presumed to be linked to the effective electron donation (see ref.34 for a discussion on substrate inhibition), 
it seems plausible that a complex of cd1NiR and cNOR forms and that the complex interface interferes with the 
access of the electron donor to cNOR. This conclusion is supported by the co-crystallised Ps. aeruginosa cd1NiR/c-
NOR complex24, which shows that the cd1NiR interacts with the NorC subunit (see Fig. 1) that harbors the initial 
electron acceptor (a heme c) of cNOR. As is clear from Fig. 3b (and Supporting Fig. 3) however, the observed 
Km for cyt. c does not change in the presence of cd1NiR but direct electron donation by TMPD is clearly affected 
(see Fig. 4). Although we have not used the presumed physiological c550 cytochrome7,35, but the readily available 
horse heart (hh) cyt. c, the structures align very well and hh cyt. c works well as electron donor to cNOR. The 
small TMPD molecule (MW: 164 g/mol) presumably has a less defined or multiple interaction surfaces on cNOR, 
as indicated by our titration data (Fig. 4), and these (or some of them) presumably overlap with the interaction 
surface for cd1NiR. We also observe inhibition by the presence of cd1NiR with the electron mediator PMS (instead 
of TMPD, see Supporting Fig. 4).
An interesting parallel is that the antibody used for crystallisation of the Ps. aeruginosa cNOR (only)21, was 
shown to interfere with electron donation from cytochrome c, but not from PMS21. The binding site for this anti-
body has some, albeit small, overlap with the binding of cd1NiR in the co-crystal complex24.
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The inhibition of cNOR activity observed upon addition of cd1NiR shows a clear correlation in extent to the 
concentration of added cd1NiR up until approximately equimolar amounts to cNOR (20–40 nM), but at higher 
concentrations of cd1NiR, the inhibition is relieved. This is a surprising but highly reproducible observation which 
we suggest could be due to an effect of dimerization of cd1NiR, which is purified and crystallized in the dimeric 
form both in P. pantotrophus6 and P. aeruginosa9. Our fluorescence intensity measurements with labeled cd1NiR 
showed a fluorescence ‘count-rate per particle’ (CPM) increase (Fig. 7), consistent with dimerization with an 
apparent KD of ~3.5 nM. To our knowledge, an apparent dimerization constant for cd1NiR has not previously 
been determined. In the P. aeruginosa cd1NiR dimer there is domain ‘swapping’ between the monomers, leading 
to a presumably obligatory dimer, whereas no such swapping occurs in the P. pantotrophus (and hence denitrif-
icans) cd1NiR. This difference is likely to affect the stability of the dimer and also the propensity to interact with 
cNOR. Also consistent with our functional data is that this KD is affected (increases) in the presence of cNOR, 
from 3.5 nM to ~5 nM, supporting an interaction between cNOR and cd1NiR in the same concentration range as 
used in the functional assay. The total CPM for cd1NiR is also affected by cNOR, and the 40 nM cNOR used in this 
experiment might not be enough to saturate the effects, such that the influence of cNOR for cd1NiR dimerization 
might be somewhat underestimated.
The Ps. aeruginosa co-complex structure, where each cd1NiR monomer binds a cNOR on opposite ‘ends’ 
(Fig. 1) is a structure that cannot be formed in vivo because of the restrictions imposed by the cytoplasmic mem-
brane. This is thus consistent with a cNOR/cd1NiR interaction that is stronger when both proteins are in their 
monomeric forms. In this context, we do see differences in the inhibition patterns when adding cd1NiR to cNOR 
in detergent versus in liposomes, but qualitatively, the results are similar (see Supporting Fig. 2).
Although the effect cd1NiR has on the maximum rate of NO-reduction was interpreted above in terms of only 
occurring for the monomer of cd1NiR, even at higher cd1NiR concentrations (i.e. when cd1NiR is predominantly a 
dimer) it still influences cNOR catalysis as seen in the plots of the Kiapp (Fig. 2b). A possible interpretation for this 
is that cd1NiR still interacts with cNOR even in its dimeric form, but that the interaction surface changes. It’s also 
possible that the effect on the cNOR substrate inhibition pattern originates from structural changes occurring in 
cd1NiR itself as a response to changes in [NO] or in reduction levels (as seen in36, see below).
Even though there are clear influences on the function of cNOR by the presence of cd1NiR, we could not find 
evidence for a high-affinity, constant complex between the P. denitrificans cd1NiR and cNOR, as indicated e.g. by 
the Western Blot results (Supporting Fig. 5) and the lack of clear differences between the interactions of (fluores-
cently labeled) cd1NiR with either the native aerobic or anaerobic (denitrifying) P. denitrificans membranes shown 
in Fig. 6c. Interpreting this data is complicated by the observation that there is a rather high affinity of the cd1NiR 
for lipid membranes (see Figs. 5 and 6), as reported also previously37,38. This interaction is not purely electrostatic 
in nature, whereas only electrostatic interactions between the d1 domain and the membrane were discussed for 
the P. aeruginosa cd1NiR-cNOR co-complex simulations24. An interaction between cd1NiR and the cytoplasmic 
membrane would enable the NO produced to directly dissolve into the membrane bilayer from which it can 
migrate to the gas channel in cNOR (see Fig. 1) without equilibrating with the bulk water phase even with no 
direct contact between the two enzymes.
Since a co-complex structure of cd1NiR-cNOR exists only for the P. aeruginosa proteins, we overlayed the 
potential interaction between the two homologous proteins from P. denitrificans. For the P. denitrificans cNOR, 
we constructed a model based on the P. aeruginosa structure (to which it has 54% (NorB) and 47% (NorC) 
sequence identity), as shown in Supporting Fig. 8A, and the Glu-119 of P. aeruginosa cNOR that forms the main 
interaction with the P. aeruginosa cd1NiR overlays well with the corresponding Asp-123 in P. denitrificans cNOR. 
Figure 7. Fluorescence intensity (count per molecule (CPM)) when adding increasing amounts of cd1NIR-
STAR 635 to a solution with (green circles) or without (red circles) 40 nM cNOR. The fluorescence intensity 
measured with increasing concentrations of cNOR-STAR 635 alone is also shown (white circles). The black 
lines are ligand-binding fits for cd1NiR dimerization, giving KD = 3.5 ± 0.1 nM (without) and 5.3 ± 0.2 nM (with 
cNOR) respectively.
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However, the P. pantotrophus cd1NiR structure (sequence identity 97% to P. denitrificans cd1NiR) shows signif-
icant differences to the cd1NiR from P. aeruginosa, and there is no Arg equivalent to the R-96 (numbering from 
our alignment (Supporting Fig. 7), corresponds to the R-71 in the alignment from Terasaka et al.24) that interacts 
with the E-119 on cNOR (in P. denitrificans and P. pantotrophus cd1NiR, the corresponding residue is a Leu). The 
structural overlay of the P. pantotrophus and P. aeruginosa cd1NiRs (see Supporting Fig. 8B) further shows that 
the cyt. c domain is more different than the d1 domain and specifically the region on cd1NiR that is interacting 
with cNOR in the Ps. aeruginosa co-crystal structure is markedly different in P. pantotrophus cd1NiR, there is a 
small N-terminal helix that would ‘clash’ with the cNOR, as shown in Fig. 8, whereas in Ps. aeruginosa cd1NiR, the 
N-terminal is involved in ‘domain swapping’ and forms part of the d1 domain (see Supporting Fig. 8C).
However, it is also known that the P. pantotrophus cd1NiR c domain structure is significantly different in the 
reduced state36, and thus suggested to undergo large-scale conformational changes upon reduction (Supporting 
Fig. 9). Such changes could affect both the cNOR interaction and the dimerization constant, since the c domain of 
cd1NiR ‘swings’ out of dimer contact in the reduced state. It is difficult to predict what would happen to a putative 
cd1NiR/cNOR complex when cd1NiR is reduced since the N-terminal ‘clashing’ helix (Fig. 8), is not even resolved 
in the reduced cd1NiR structure36, and there is hardly any overlap between the oxidised and reduced c domain 
structures (Supporting Fig. 9). Presumably the interaction between P. denitrificans cNOR and cd1NiR, if it occurs 
using a similar interaction surface as in Ps. aeruginosa, would affect this cd1NiR conformational change and 
hence could be involved in controlling cd1NiR activity. We also note that in our functional cNOR assays, cd1NiR is 
presumably predominantly in the reduced state (depending on if it has turned over, see39) since there is an excess 
reductant and no nitrite added.
So, are there physiological consequences of having an interaction between the cd1NiR monomer and cNOR 
that becomes much less pronounced once the cd1NiR dimerizes? It is possible that such regulation on the enzyme 
level (on top of the major transcriptional regulation) is there to fine tune flux through denitrification in response 
to rapidly fluctuating environmental conditions and is especially important when expression levels are low.
Materials and Methods
cd1NiR; growth of bacteria and purification. Paracoccus pantotrophus (G6) was grown anaerobically 
and cd1NiR purified essentially as in5. Briefly, bacteria were grown until OD600 ~0.8 in a medium containing 
nitrate as electron acceptor and acetate as carbon source, supplemented with 50 µg/ml kanamycin. To obtain the 
periplasmic fraction, the cell pellet was resuspended in 200 mL buffer containing 0.5 M sucrose, 3 mM EDTA, 
100 mM Tris-HCl, pH 8.0, and 400 mg of lysozyme was added. The solution was then incubated with constant 
stirring at 30 °C for 40 minutes. The cell solution was then centrifuged at 25000 g for 10 min. The supernatant 
(containing the periplasm) was applied to a DEAE anionic-exchange column (GE Healthcare), from which bound 
fractions were eluted with a 0–300 mM NaCl gradient in 100 mM Tris/HCl pH 8.0. The brown-colored fractions 
were pooled, solid ammonium sulfate was added to 40% (w/v) and the precipitated protein removed by centrifu-
gation at 30000 g for 30 min.
Figure 8. (a) The model of the P. denitrificans cNOR (NorB in magenta, NorC in salmon) and the P. 
pantotrophus cd1NiR monomer structure (blue, PDB ID: 1QKS6) overlapped on the cd1NiR/cNOR co-complex 
structure from P. aeruginosa (PDB ID: 5GUW24 (not shown)). The cd1NiR helix that interacts with NorC (in the 
co-complex) in light blue and the ‘extra’ N-terminal helix in purple. Note that this ‘extra’ helix would clash into 
the NOR/NiR interface. Shown is also the D123 (stick) of NorC (equivalent to the E-119 in Ps. aeruginosa) and 
the heme groups of the proteins. (b) Zoom-in of interface. The picture outlines also the surface (transparent) of 
the proteins except for the ‘extra’ helix.
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The solution was applied to a phenyl-sepharose column (GE Healthcare), and a 40-0% ammonium sulfate gra-
dient was applied. The fractions that contained pure cd1NiR (A406/A280 ~1.25)8 were pooled and concentrated. The 
concentration of cd1NiR was determined by using ε418 = 268 mM−1 cm−1. For antibody generation the enzyme 
was further purified using size exclusion chromatography in 100 mM Tris/HCl pH 7.0 on a Superose 10/300 
column (GE-Healthcare).
cNOR; growth of bacteria, protein purification and model building. Purification of cNOR (P. deni-
trificans overexpressed in E. coli) was performed as described in18, based on the original protocol from40. Briefly, 
the plasmid pNOREX was transformed in to a JM109 strain which contained the pEC86 vector40. cNOR expres-
sion was induced by IPTG. The membranes were solubilized in 100 mM Tris, pH 7.6, 50 mM NaCl, 1 mM EDTA 
and 1% n-dodecyl-β-D-maltoside (DDM). The membrane solution was incubated with constant stirring for 
1 hour at 4 °C. The unsolubilized membranes were removed by centrifugation, and the supernatant was applied to 
a Q-Sepharose high performance (GE-HealthCare) column, which was equilibrated in 20 mM Tris/HCl pH 7.6, 
0.04% DDM and 5 mM NaCl. The column was washed with the same buffer but containing 250 mM NaCl and 
cNOR was eluted with a 250 mM-500 mM NaCl gradient in 20 mM Tris/HCl pH 7.6, 0.04% DDM.
The pure fractions of cNOR were pooled, diluted 3 times in 100 mM Tris/HCl, 50 mM NaCl, and the concen-
tration of NaCl was lowered to below 50 mM by repeated dilution and reconcentration in concentrating vials 
(Millipore Merck, Ltd). Aliquots were flash frozen in liquid nitrogen and stored in −80 °C.
The structural model of P. denitrificans cNOR was constructed with SWISS-MODEL (https://swissmodel.
expasy.org) using the default parameters and refinement procedure. The crystal structure of Pseudomonas aerug-
inosa cNOR (PDB ID: 3o0r21, sequence identity 54% for NorB and 47% for NorC) was used as the structural 
template. The P. denitrificans cNOR could also be modelled on the Roseobacter denitrificans cNOR (sequence 
identity 75% for NorB and 69% for NorC) structure41, but since this cNOR, unlike P. denitrificans cNOR, was 
found to bind a Cu+ ion in the NorC subunit, which could potentially influence the region around the presumed 
interaction with cd1NiR, we chose to use the P. aeruginosa cNOR–derived model.
Detection of cd1NiR in anaerobically grown (on nitrate) P. denitrificans cells. P. denitrificans 
(Pd1222) cells were grown anaerobically on nitrate (32 mM) as electron acceptor at 37 °C, the cells were harvested 
and the periplasm was obtained by osmotic shock as described above. The pellet was sonicated, and the membranes 
were extracted by high-speed centrifugation (100 000 g). The different cell components (whole cell, periplasm (PL) 
and membrane (M) fractions) were subjected to SDS-PAGE (Invitrogen, 4–12%) analysis followed by Western blot 
using a PDVF membrane and an antibody against cd1NiR, obtained from Biogenes GmbH (Germany).
protein reconstitution in vesicles. For the generation of small unilamellar vesicles (SUVs), a solution 
of 40 mg/ml soybean lipids in 50 mM Tris/HCl pH 7.0, 50 mM KCl was sonicated until it became clear. 2–4 µM 
cNOR was added to the liposomes in the presence of 0.6% Na-cholate and the mixture was incubated for 1 hour at 
22 °C. The detergent was then removed on a PD-10 column (GE-Healthcare). For generation of large unilamellar 
vesicles (LUVs), DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) lipids dissolved in CHCl3 were dried and 
then rehydrated to 2 mM in a 10 mM phosphate buffer (pH 7.4) with 2 mM KCl. Unilammelar liposomes were 
made by passing the lipid solution trough a filter with a 100 nm pore size 21 times. cNOR was reconstituted into 
the liposomes by gently solubilizing the vesicles with 0.6% Na-Cholate before adding the protein at a 10:1 molar 
ratio (protein: liposome), giving a protein to lipid ratio of ca. 1:3500 in the outer monolayer. The detergent was 
then slowly removed by dialysis at 4 °C over night.
For generation of giant unilamellar vesicles (GUVs), a 1 mM stock solution of DOPC supplemented with 1% 
DPPE-biotinyl (2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-biotinyl) (Avanti Polar Lipids) was used according 
to the procedure described in42. cNOR labelled with ATTO 594 (see below) was reconstituted into the GUVs using a 
mild detergent treatment with DDM; the protein solution containing 1 mM DDM was mixed with 20 μl GUV-solution 
to a final concentration of 0.05–0.25 μM protein and 0.05 mM DDM and incubated at room temperature for 30 min. 
The proteo-GUVs were then diluted 20 times in a 100 mM buffered glucose solution (10 mM phosphate buffer pH 7.4, 
2 mM KCl) and transferred to a LabTek microscope chamber coated with streptavidin and further incubated at room 
temperature for 2 h. The dilution gave a final detergent concentration of 2.5 μM DDM in the sample.
Steady-state activity measurements. The interaction between cNOR and cd1NiR was investigated by 
studying the multiple turnover activity of cNOR, either in detergent (0.05% DDM) or incorporated in vesicles, using 
a Clark-type electrode (World Precision Instruments, WPi) as in18. Briefly, the activity was measured in 50 mM 
HEPES at pH 7.0 with 50 mM KCl at room temperature. The buffer in the reaction chamber (total volume = 1 ml) 
was made anaerobic by adding the glucose (30 mM)/glucose oxidase (1 U/ml)/catalase (20 U/ml) system. Substrates 
were added with a syringe in the following order, horse heart (hh) cyt. c (varying concentrations), TMPD at varying 
concentrations, 5 equal additions of 10 µM NO (from NO-saturated water), and 3 mM sodium ascorbate. cNOR 
was added at various concentrations (20–80 nM) either prior to (cNOR in vesicles) or after all substrate additions 
(detergent solubilized). cd1NIR was added prior to the addition of NO, when specified. The data was recorded with 
the LabScribe2 software (WPi), and the maximum NO-reduction rate was calculated (at ~5 µM NO).
fluorescence labelling. cd1NiR and cNOR were fluorescently labelled using amino-reactive dyes. The pro-
tein concentration was set to 3 mg/ml and a 1/20 volume of NaHCO3 (pH 9.0) was added. cd1NiR was labelled 
with a 5-fold molar excess of Abberior STAR 635 (Abberior GmbH) and cNOR was labelled with a 3-fold molar 
excess of ATTO 594 (ATTO Tec GmbH) by incubating at room temperature while gently shaking for 1.5 h. 
Unbound dye was removed using a PD-10 column (GE Healthcare), equilibrated with a 10 mM phosphate buffer 
(pH 7.4) supplemented with 100 mM sucrose, 2 mM KCl and 1 mM (~0.05%) DDM.
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Fluorescence correlation spectroscopy (FCS) measurements and analyses. FCS measurements 
were performed on an instrument from Abberior Instruments (Göttingen, Germany), built on a stand from 
Olympus (IX83), and modified for two-color imaging (see42 for a detailed desciption of the experimental set 
up). Two fiber-coupled, pulsed (20 MHz) diode lasers emitting at 637 nm (PicoQuant AG, Berlin) and 594 nm 
(Abberior Instruments) were used for excitation, with the excitation pulses of the two lasers out of phase, to min-
imize cross-talk and enable fluorescence cross correlation of cd1NiR-STAR 635 on the membrane surface of the 
GUVs containing cNOR-ATTO 595. For details on the correlation and cross correlation analysis, see42,43.
The diffusion time of cd1NiR-STAR 635 (5 nM) was determined with FCS in the presence of increasing con-
centration of LUVs, with or without reconstituted cNOR. Normalized autocorrelation curves of the recorded 
fluorescence intensity fluctuations, G(τ), were calculated using a MatLab script, and the recorded G(τ) curves 
were then fitted using a model for 3D-diffusion, including two diffusional components and a population of a 
non-fluorescent triplet state (T) with a relaxation time τT:
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Here, τD1 is the diffusion time of free cd1NiR-STAR 635 and τD2 is the diffusion time of LUV-bound cd1NiR-STAR 
635. β = ω2/ω1, where ω2 and ω1 denote the 1/e2 extension of the FCS detection volume in along and perpendicular 
to the excitation beam direction, respectively. N is the average number of fluorescent molecules in the detection 
volume, and a and b the fractions of fluorescent molecules belonging to each of the two different diffusion com-
ponents (with a + b = 1) The amplitudes of the component with diffusion time τD2 were fitted with the binding 
model:
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where Fm represents fraction of liposomes bound to cd1NiR-STAR 635, csol represents non-bound liposomes (plot-
ted as number of free lipids), and KD is the binding constant defined by the concentration at which half of the 
liposomes are bound (Fm = 0.5). The value of Fm
max was set to unity.
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